Tag Archives: Intellectual property

Statement by Communist Party of India (Marxist) on India-EU FTA

Posted on February 9, 2012 by

India-EU Free Trade Agreement : Resolutely Safeguard Indian Interests The Indo-EU summit on 10th February is preparing to finalise the contours of the EU-India Free Trade Agreement. The CPI(M) expresses grave concern on the total lack of transparency regarding the … Continue reading →

Posted in access to medicines, EU-India FTA, IP Rights | Tagged | Leave a comment

Wikileaks: US lobbied for keeping data exclusivity and patent evergreening in Phillipines’ Medicine Act

Posted on November 8, 2011 by

WikiLeaks: US lobbied vs cheaper medicine law in Phillipines Sheila Crisostomo Source: The Phillipine Star, 8 Nov 2011 MANILA, Philippines - The online whistle-blower WikiLeaks reported that the United States had lobbied against the Cheaper Medicine Act in the Philippines after American … Continue reading →

Posted in data exclusivity, patent evergreening, TRIPS plus | Tagged , , | Leave a comment

IP-Watch: “Washington Declaration” Demands Return Of Public Interest In IP Rights

Posted on September 15, 2011 by

By William New, Intellectual Property Watch on 10/09/2011 A new multi-stakeholder declaration demanding that the public interest be returned to intellectual property rights was issued this week and is open for signatures by anyone, already collecting hundreds of supporters. The … Continue reading →

Posted in ACTA, Generic drug, IP Rights, Trans-Pacific Partnership Agreement | Tagged | Leave a comment

Industry paid for IP seminars to train judges

Posted on September 15, 2011 by

Author(s): Latha Jishnu Issue Date: 2011-9-14 Source: Down to Earth Microsoft and Indian Music Industry funded FICCI to hold roundtable for Maharashtra judiciary; judges handling piracy cases special invitees Leaked documents of correspondence between lobby group FICCI and industry have … Continue reading →

Posted in intellectual property training | Tagged , , , , , | Leave a comment

AIDS groups seek help to counter ‘ever-green patents’

Posted on September 13, 2011 by

By Petchanet Pratruangkrai Source: The Nation September 13, 2011People with HIV/AIDS have called for the Intellectual Property Department to amend the application process for drugs to pave the way for greater access to life-saving medicines amid plans by producers to … Continue reading →

Posted in patent evergreening | Tagged , , | Leave a comment

Novartis attempt to get Data Exclusivity in Argentina on Glivec

Posted on September 5, 2011 by

Novartis is not just trying to weaken the Indian patent law, it is making several attempts in other countries as well for better Intellectual Property protection.  See the court decision below rejecting an attempt by Novartis to get data exclusivity … Continue reading →

Posted in data exclusivity, Indian Patent Law | Tagged , , , | Leave a comment

European Commission’s report on IPR infringed goods detained by Customes

Posted on July 15, 2011 by

The European Commission released its annual report on customs activities related to intellectual property rights (IPR) infringing goods and called for new enforcement measures. The report says that 93% of the medicinal products detained by EU customs officials were from … Continue reading →

Posted in Generic drug, IPR infringement, seizures | Tagged , | Leave a comment

MSF Press Release: India Says ‘No’ to Policy That Would Block Access to Affordable Medicines

Posted on June 23, 2011 by

Focus Shifts to Remaining Harmful Provisions in EU-India Trade Deal  NEW DELHI/BRUSSELS, June 22, 2011–At the United Nations High Level Meeting on HIV and AIDS in early June, India announced that it will not accept data exclusivity, a provision harmful … Continue reading →

Posted in data exclusivity, EU-India FTA, IPR Enforcement | Tagged , , , | 1 Comment

India-EU Agreement May Restrict Low-Cost Drugs

Posted on June 23, 2011 by

From the Economic Times, 22 JUN, 2011 Khomba Singh NEW DELHI: Global health groups have urged the government to scrap certain provisions in its ongoing trade discussions with European countries saying there are other provisions to restrict access of low cost … Continue reading →

Posted in data exclusivity, EU-India FTA, Generic drug, IPR Enforcement, TRIPS plus | Tagged , , | Leave a comment

IP negotiations at the UN High-Level Meeting on HIV/AIDS

Posted on May 27, 2011 by

UN High Level Meeting on HIV/AIDS is set to take place from 8–10 June 2011 in New York to review progress and chart the future course of the global AIDS response. Member States are expected to adopt a new Declaration … Continue reading →

Posted in HIV/Aids, TRIPS, TRIPS plus, UN General Assembly HLM | Tagged , , , , , , , , | 3 Comments